Angela Collarino, Sergi Vidal-Sicart, Renato A. Valdés Olmos (Editors). Nuclear Medicine Manual on Gynaecological Cancers and Other Female Malignancies Luigi Mansi Book Review 22 March 2023 Pages: 1841 - 1841
Astatine-211 for PSMA-targeted α-radiation therapy of micrometastatic prostate cancer: a sustainable approach towards precision oncology Rubel ChakravartyXiaoli LanWeibo Cai Editorial 02 March 2023 Pages: 1844 - 1847
FAPI PET/CT in infectious, inflammatory, and rheumatological diseases: “watch it like a hawk” or “one swallow does not make a summer”? Giorgio TregliaDomenico Albano Editorial 06 March 2023 Pages: 1848 - 1850
Q.Clear reconstruction for reducing the scanning time for 68 Ga-DOTA-FAPI-04 PET/MR imaging Weiwei RuanChunxia QinXiaoli Lan Original Article 27 February 2023 Pages: 1851 - 1860
EANM enabling guide: how to improve the accessibility of clinical dosimetry Jonathan GearCaroline StokkePablo Minguez Gabiña Guidelines Open access 22 April 2023 Pages: 1861 - 1868
Predictive value of 18F-FDG PET/CT-based radiomics model for neoadjuvant chemotherapy efficacy in breast cancer: a multi-scanner/center study with external validation Kun ChenJian WangWengui Xu Original Article 20 February 2023 Pages: 1869 - 1880
A cycle-consistent adversarial network for brain PET partial volume correction without prior anatomical information Amirhossein SanaatHossein ShooliHabib Zaidi Original Article Open access 20 February 2023 Pages: 1881 - 1896
Validation of simplified uptake measures against dynamic Patlak Ki for quantification of lesional 89Zr-Immuno-PET antibody uptake Jessica E. WijngaardenMarc C. HuismanRonald Boellaard Original Article Open access 23 February 2023 Pages: 1897 - 1905
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies Bastiaan M. PrivéMohamed A. BoussihmadHarm Westdorp Review Article Open access 23 February 2023 Pages: 1906 - 1918
Diagnostic efficiency of [68 Ga]Ga-DOTA-FAPI-04 in differentiating periprosthetic hip joint infection and aseptic failure Yiqun WangRuimin WangJiahe Tian Original Article 23 February 2023 Pages: 1919 - 1928
[89Zr]-immuno-PET prediction of response to rituximab treatment in patients with therapy refractory interstitial pneumonitis: a phase 2 trial H. AdamsE. M. W. van de GardeR. G. Keijsers Original Article Open access 24 February 2023 Pages: 1929 - 1939
The prognostic value of CZT SPECT myocardial blood flow (MBF) quantification in patients with ischemia and no obstructive coronary artery disease (INOCA): a pilot study Han ZhangFederico CaobelliFei Yu Original Article Open access 14 February 2023 Pages: 1940 - 1953
[18F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review Elze R. TimmersMarrit R. KlamerMarina A. J. Tijssen Review Article Open access 27 January 2023 Pages: 1954 - 1973
A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice Youssef ChahidZulfiqar H. SheikhJan Booij Review Article Open access 27 February 2023 Pages: 1974 - 1987
The diagnostic performance of functional dopaminergic scintigraphic imaging in the diagnosis of dementia with Lewy bodies: an updated systematic review Mario JreigeGeorge K. KurianJohn O. Prior Review Article Open access 15 March 2023 Pages: 1988 - 2035
Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways Cecilia BoccaliniNicolas NicastroValentina Garibotto Original Article Open access 24 February 2023 Pages: 2036 - 2046
Regional brain glucose metabolism is differentially affected by ketogenic diet: a human semiquantitative positron emission tomography Tatiana HorowitzEmilie DocheEric Guedj Original Article 03 March 2023 Pages: 2047 - 2055
68Ga-cyc-DX600 PET/CT in ACE2-targeted tumor imaging Fangyuan RenHongyang JiangQiang Li Original Article 27 February 2023 Pages: 2056 - 2067
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC Iris H.C. MiedemaMarc C. HuismanIdris Bahce Original Article Open access 02 March 2023 Pages: 2068 - 2080
Preclinical evaluation of a brain penetrant PARP PET imaging probe in rat glioblastoma and nonhuman primates Baosheng ChenDevi Prasan OjhaZhengxin Cai Original Article 28 February 2023 Pages: 2081 - 2099
EDB-FN targeted probes for the surgical navigation, radionuclide imaging, and therapy of thyroid cancer Ruping LiHuihui HeWei Fan Original Article 18 February 2023 Pages: 2100 - 2113
The performance of 68Ga-FAPI-04 PET/CT in head and neck squamous cell carcinoma: a prospective comparison with 18F-FDG PET/CT Yaqun JiangBing WenYong He Original Article 20 February 2023 Pages: 2114 - 2126
Direct co-registration of [18F]FDG uptake and histopathology in surgically excised malignancies of the head and neck: a feasibility study Jens M. DebackerLuna MarisWouter Huvenne Original Article 01 March 2023 Pages: 2127 - 2139
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [18F]FDG-PET/CT parameters Julian M. M. RogaschLiza MichaelsTobias Penzkofer Original Article Open access 23 February 2023 Pages: 2140 - 2151
Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma Li JinghuaXu KuiYuan Yufeng Original Article 21 February 2023 Pages: 2152 - 2166
The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer Adriano Basso DiasSeyed Ali MirshahvaladPatrick Veit-Haibach Original Article 21 February 2023 Pages: 2167 - 2176
A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer Xiaomei GaoYongxiang TangShuo Hu Original Article 22 February 2023 Pages: 2177 - 2187
Adoption of Lutetium-177 PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020 Luka FlegarSmita George ThodukaJohannes Huber Original Article Open access 24 February 2023 Pages: 2188 - 2195
Evaluation of thresholding methods for the quantification of [68Ga]Ga-PSMA-11 PET molecular tumor volume and their effect on survival prediction in patients with advanced prostate cancer undergoing [177Lu]Lu-PSMA-617 radioligand therapy Moon KimRobert SeifertJens Kleesiek Original Article Open access 02 March 2023 Pages: 2196 - 2209
225Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings Mike SathekgeFrank BruchertseiferChristophe Van de Wiele Original Article Open access 03 March 2023 Pages: 2210 - 2218
First-time rest-stress dynamic whole-body 82Rb-PET imaging using a long axial field-of-view PET/CT scanner Federico CaobelliSigrid SeibelAxel Rominger Image of the Month Open access 27 April 2023 Pages: 2219 - 2221
[68Ga]Ga-PSMA-11 and [18F]FDG uptake of venous tumor thrombus in inferior vena cava and left common iliac vein from prostate cancer on positron emission tomography Hulya SeymenBaris EsenYakup Kordan Image of the Month 11 January 2023 Pages: 2222 - 2223
18F-FDG PET/CT findings in autopsy confirmed a case of ischemic cardiac disease at an early stage Osamu ManabeTakunori TsukuiHideo Fujita Image of the Month 24 January 2023 Pages: 2224 - 2225
Liver metastasis of a neuroendocrine tumor demonstrates intense uptake in PSMA-PET—but not its lymph-node metastasis and primary-tumor Erik WinterStefanie ZschäbitzClemens Kratochwil Image of the Month Open access 13 February 2023 Pages: 2226 - 2227
Diffusely increased breast uptake of [18F]AlF-NOTA-FAPI-04 related to menstrual status in a patient with papillary thyroid cancer Tao HeXiangyu LiHuawei Cai Image of the Month 27 February 2023 Pages: 2228 - 2229
Correction to: Clinical prospective study of Gallium 68 (68Ga)–labeled fibroblast‑activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma Li JinghuaXu KuiYuan Yufeng Correction 17 March 2023 Pages: 2230 - 2230